A new release to help doctors on their every day work to improve health.
In our mission to help all doctors in finding the best therapy for their patients, we are happy to announce that we now support a new disease: arterial hypertension. This new release will help cardiologists in their therapy decision. On top of that, it completes, even more, the diabetes type 2 version, since hypertension is a common comorbidity of this disease.
Request a showcase and see the new features live by contacting us at email@example.com
Arterial hypertension therapy decision support
The solution presents non-drug therapies and authorized drugs against arterial hypertension. Each therapy is presented as a card, showing all relevant factors for making a therapy decision as results in standardized values, so doctors can understand and compare the therapies.
Let’s explore the features that the arterial hypertension version presents to make the therapy decision:
The database contains all contraindications reported in product authorizations of every therapy shown. If any patient’s detail is captured that serves as a reason to withhold a therapy, the software labels it as dangerous or suboptimal therapy and a warning appears explaining it.
Age, gender, behaviour, risk factors, laboratory values, comorbidities and patient’s history, among others, are used to determine contraindications.
Drug-drug interaction check: Whenever a patient is taking two or more drugs or substances, there is a possibility that there will be an interaction among them. If there is an observed interaction between one of those substances and a therapy, the software presents an explanation including the severity level, the effects it causes over the other substance, and the recommended action.
On top of that, the drug interaction check respects the complexity of the human body (observed interactions together with metabolic overlap). Since it provides different levels of severity, only the relevant information is given to the doctor.
Guidelines adherence: The arterial hypertension version follows the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) guidelines. Users can visualize the therapies that follow each one of the steps specified in the guidelines and their recommendations.
Combination therapies: There are several factors that doctors need to consider when prescribing a combination of therapies. The problem is that there is not one combination right for the same category of people. 1
As an answer to this problem, RAMPmedical introduces the possibility to combine therapies to make an evaluated decision. Doctors can choose the main therapeutic families that they would like to combine. As a result, the software presents all the possible results of a dual, triple or quadruple combination. Each possible combination will appear as a card, allowing the doctor to understand and compare these therapies.
Effect table: The effect table presents the improvements of a therapy regarding several end-points. The table shows the effects that different dosage has and the evidence behind each value.
RAMPmedical now works on multiple devices. This means that the software automatically adjusts and adapts to any device screen size, whether it is a desktop, a laptop, a tablet, or a mobile phone. Content, design, performance and usability are the same quality across all devices.
Part of the work of the last months was determined to have a new version written in React. What does this mean? React is a computer language based on user interface components, so it is easier and faster to make changes on the front end. As a result, while we are developing and understanding new medical fields, implementing those changes can be done more efficiently since the front end is more flexible. This didn’t only allow us to add the hypertension version but also to achieve technical scalability.
Behind the React language, there is an application program interface (API), which is a set of protocols and tools that specifies how software components should interact. The API supports hospital information system specifications, allowing a seamless integration in the hospital workflow.
In other words, thanks to these new technical improvements, RAMPmedical can exchange data with hospital applications, such as electronic health records, without sacrificing information integrity.
Rewrite of the database
Until now, RAMPmedical’s database included data from product characteristics, medical guidelines, clinical trials, and scientific articles. To ensure that our software could handle even more complex information, during the last month we decided to rewrite our database. One of the advantages of this new database is the possibility to compare different units without jeopardizing the authenticity of the information. To do so, we needed to restructure the information, allowing the software to make more precise recommendations.